Ethallobarbital
Ethallobarbital is a barbiturate derivative that was developed in the early 20th century. It is known for its sedative and hypnotic properties, which make it useful in the treatment of insomnia and other sleep disorders.
Chemical Structure and Properties
Ethallobarbital belongs to the class of barbiturates, which are derivatives of barbituric acid. The chemical structure of ethallobarbital includes a pyrimidine ring fused with a urea moiety, and it is characterized by the presence of an ethyl group at the 5-position of the barbituric acid core.
Pharmacology
Ethallobarbital acts on the central nervous system (CNS) by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter. This action results in increased GABA-ergic inhibition, leading to sedative and hypnotic effects. The drug is metabolized in the liver and excreted through the kidneys.
Medical Uses
Ethallobarbital has been used primarily for its sedative and hypnotic effects. It is prescribed for the short-term treatment of insomnia and for inducing anesthesia in medical procedures. Due to the risk of dependence and the development of safer alternatives, its use has declined over the years.
Side Effects and Risks
Common side effects of ethallobarbital include drowsiness, dizziness, and headache. Prolonged use can lead to tolerance, dependence, and withdrawal symptoms. Overdose can result in severe respiratory depression, coma, and even death.
History
Ethallobarbital was first synthesized in the early 20th century as part of the development of barbiturate drugs. It was one of many barbiturates used for their sedative and hypnotic properties before the advent of benzodiazepines and other modern sedatives.
Regulation
Due to its potential for abuse and dependence, ethallobarbital is classified as a controlled substance in many countries. Its use is strictly regulated, and it is available only by prescription.
See Also
References
Lua error in package.lua at line 80: module 'strict' not found.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
